Neovasc Inc. Operating Income

Operating Income of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income growth rates and interactive chart. Operating income is the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation, and cost of goods sold (COGS). Operating income–also called income from operations–takes a company's gross income, which is equivalent to total revenue minus COGS, and subtracts all operating expenses. A business's operating expenses are costs incurred from normal operating activities and include items such as office supplies and utilities. Operating income is measured before interest and tax expenses and is a good gauge of a company's operational profitability.


Highlights and Quick Summary

  • Operating Income for the quarter ending March 31, 2022 was $-6.62 Million (a 29.26% increase compared to previous quarter)
  • Year-over-year quarterly Operating Income decreased by -27.22%
  • Annual Operating Income for 2021 was $-31.1 Million (a -11.54% decrease from previous year)
  • Annual Operating Income for 2020 was $-35.2 Million (a 17.04% increase from previous year)
  • Annual Operating Income for 2019 was $-30 Million (a -7.29% decrease from previous year)
  • Twelve month Operating Income ending March 31, 2022 was $-27.6 Million (a -11.43% decrease compared to previous quarter)
  • Twelve month trailing Operating Income decreased by -28.65% year-over-year
Trailing Operating Income for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-27.6 Million $-31.1 Million $-35.2 Million $-38.6 Million
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income of Neovasc Inc.

Most recent Operating Incomeof NVCN including historical data for past 10 years.

Interactive Chart of Operating Income of Neovasc Inc.

Neovasc Inc. Operating Income for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-6.62
2021 $-5.12 $-6.72 $-9.09 $-10.17 $-31.11
2020 $-9.19 $-10.17 $-8.66 $-7.16 $-35.17
2019 $-9.57 $-6.99 $-6.63 $-6.85 $-30.05
2018 $-10.25 $-9.65 $-6.0 $-6.5 $-32.41
2017 $-12.21 $-5.83 $-6.3 $-7.82 $-32.15
2016 $-6.73 $-7.59 $-12.99 $-9.51 $-36.82
2015 $-8.06 $-8.67 $-6.83 $-5.18 $-28.76
2014 $-7.09 $-4.38 $-5.91 $-0.37 $-17.27
2013 $-2.23 $-1.34 $-1.36 $-1.94 $-6.9
2012 $-1.0 $-1.2 $-1.49 $-1.24 $-4.92
2011 $1.8 $-3.88

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.